About the Authors

Gregory L. Price

glp@lilly.com

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

Keith L. Davis

Affiliation RTI Health Solutions, Research Triangle Park, North Carolina, United States of America

Sudeep Karve

Affiliation RTI Health Solutions, Research Triangle Park, North Carolina, United States of America

Gerhardt Pohl

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

Richard A. Walgren

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

Competing Interests

Gregory L. Price, Gerhardt Pohl, and Richard A. Walgren are employees of Eli Lilly and Company, whose company funded this study. Keith L. Davis and Sudeep Karve are employees of RTI Health Solutions. Eli Lilly and Company is pursuing innovative drug development in the MPNs. There are no other relevant patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: GLP KLD SK GP RAW. Performed the experiments: GLP KLD SK GP RAW. Analyzed the data: GLP KLD SK GP RAW. Contributed reagents/materials/analysis tools: GLP KLD SK GP RAW. Wrote the paper: GLP KLD SK GP RAW.